Star Wars: Jedi Knights Comic to Premiere Lost Toy Villain Atha Prime - MSN
2 days ago • Google News
Athira Pharma Inc (ATHA)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 15.8M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 3.51
52W Low
$ 0.22
Dividend Yield
0.00%
Beta
3.01
Technicals
50-Day MA
0.3663
200-Day MA
0.4233
52 Week High
3.51
52 Week Low
0.2195
About ATHA
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Employees
26
Headquarters
Bothell, WA
CEO
Dr. Mark J. Litton M.B.A., Ph.D.